Topics

Investigational Drug Promising in Obese Patients With Diabetes

08:53 EST 8 Nov 2019 | Medscape

An investigational agent originally developed for sarcopenia has shown promise in a phase 2 trial in those with obesity and type 2 diabetes, leading to a loss of body fat as well as weight reduction.
Medscape Medical News

Original Article: Investigational Drug Promising in Obese Patients With Diabetes

NEXT ARTICLE

More From BioPortfolio on "Investigational Drug Promising in Obese Patients With Diabetes"

Quick Search

Relevant Topic

Obesity
Obesity is the condition in which excess fat has accumulated in the body (mostly in subcutaneous tissues). clinical obesity is considered to be present when a person has a BMI of over 30 (Oxford Dictionary of Medicine). It is becoming increasing common i...